LPL Financial’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,552
| Closed | -$349K | – | 5802 |
|
|
2025
Q2 | $349K | Sell |
3,552
-27,784
| -89% | -$2.63M | ﹤0.01% | 4669 |
|
|
2025
Q1 | $2.9M | Buy |
31,336
+605
| +2% | +$55.8K | ﹤0.01% | 2601 |
|
|
2024
Q4 | $2.79M | Sell |
30,731
-1,794
| -6% | -$165K | ﹤0.01% | 2552 |
|
|
2024
Q3 | $3.14M | Buy |
32,525
+2,157
| +7% | +$210K | ﹤0.01% | 2335 |
|
|
2024
Q2 | $2.79M | Buy |
30,368
+18,817
| +163% | +$1.75M | ﹤0.01% | 2325 |
|
|
2024
Q1 | $1.06M | Sell |
11,551
-8,707
| -43% | -$816K | ﹤0.01% | 3124 |
|
|
2023
Q4 | $1.93M | Buy |
20,258
+75
| +0.4% | +$7K | ﹤0.01% | 2437 |
|
|
2023
Q3 | $1.89M | Buy |
20,183
+12,292
| +156% | +$1.14M | ﹤0.01% | 2341 |
|
|
2023
Q2 | $722K | Sell |
7,891
-225
| -3% | -$18.5K | ﹤0.01% | 3136 |
|
|
2023
Q1 | $597K | Sell |
8,116
-406
| -5% | -$35.1K | ﹤0.01% | 3175 |
|
|
2022
Q4 | $712K | Buy |
8,522
+4,573
| +116% | +$412K | ﹤0.01% | 2931 |
|
|
2022
Q3 | $382K | Buy |
3,949
+155
| +4% | +$18.5K | ﹤0.01% | 3384 |
|
|
2022
Q2 | $399K | Buy |
3,794
+503
| +15% | +$64.3K | ﹤0.01% | 3389 |
|
|
2022
Q1 | $567K | Buy |
3,291
+22
| +0.7% | +$3.29K | ﹤0.01% | 3092 |
|
|
2021
Q4 | $529K | Sell |
3,269
-36
| -1% | -$5.79K | ﹤0.01% | 3231 |
|
|
2021
Q3 | $493K | Sell |
3,305
-314
| -9% | -$65.3K | ﹤0.01% | 3223 |
|
|
2021
Q2 | $886K | Sell |
3,619
-472
| -12% | -$124K | ﹤0.01% | 2667 |
|
|
2021
Q1 | $1.08M | Buy |
4,091
+323
| +9% | +$91.1K | ﹤0.01% | 2330 |
|
|
2020
Q4 | $1.1M | Sell |
3,768
-91
| -2% | -$23.3K | ﹤0.01% | 2103 |
|
|
2020
Q3 | $912K | Buy |
3,859
+258
| +7% | +$58.7K | ﹤0.01% | 2017 |
|
|
2020
Q2 | $715K | Sell |
3,601
-122
| -3% | -$22.8K | ﹤0.01% | 2100 |
|
|
2020
Q1 | $683K | Sell |
3,723
-5,904
| -61% | -$1.05M | ﹤0.01% | 1881 |
|
|
2019
Q4 | $1.61M | Buy |
9,627
+6,658
| +224% | +$990K | ﹤0.01% | 1510 |
|
|
2019
Q3 | $389K | Sell |
2,969
-511
| -15% | -$66.5K | ﹤0.01% | 2468 |
|
|
2019
Q2 | $423K | Sell |
3,480
-393
| -10% | -$46.6K | ﹤0.01% | 2400 |
|
|
2019
Q1 | $477K | Buy |
3,873
+1,308
| +51% | +$164K | ﹤0.01% | 2262 |
|
|
2018
Q4 | $300K | Buy |
+2,565
| New | +$302K | ﹤0.01% | 2464 |
|
Other funds holding AMED
IA
MCI
HNB
LPL Financial's AMED Position: Q3 2025 in Review
LPL Financial sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,552 shares — an estimated $349K sold.
LPL Financial first reported a position in AMED in Q4 2018 and held it in 27 quarters. The position peaked at $3.14M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- LPL Financial reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- LPL Financial sold 3,552 Amedisys shares in Q3 2025, an estimated $349K.
- LPL Financial first reported a position in Amedisys in Q4 2018 and held it in 27 quarters.
- LPL Financial's Amedisys position peaked at $3.14M in Q3 2024.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on LPL Financial's 13F filing for Q3 2025, filed 12 Nov 2025.